A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract


Authors: Powles, T.; Fizazi, K.; Gillessen, S.; Drake, C. G.; Rathkopf, D. E.; Narayanan, S.; Green, M. C.; Mecke, A.; Schiff, C.; Sweeney, C.
Abstract Title: A phase III trial comparing atezolizumab with enzalutamide vs enzalutamide alone in patients with metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Start Page: 284s
Language: English
ACCESSION: WOS:000411931703078
DOI: 10.1200/JCO.2017.35.15_suppl.TPS5090
PROVIDER: wos
Notes: Meeting Abstract: TPS5090 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dana Elizabeth Rathkopf
    272 Rathkopf